ASML slid as much as 8% on China's DUV breakthrough. We see opportunity

On 27 July 2026, ASML shares fell as much as 8% intraday and closed down roughly 6%, near USD 1,655 after reports that a Chinese state-backed consortium has begun mass-producing domestic immersion DUV lithography tools. We believe the market’s reaction has significantly outpaced the substance of the news, and we reiterate our buy rating on ASML.

Tan De Jun, CFA
Tan De Jun, CFA28 Jul 2026 450 Views
ASML slid as much as 8% on China's DUV breakthrough. We see opportunity

ASML’s shares fell more than 8% intraday and closed roughly 6% lower following reports that a Chinese state-backed consortium had begun mass-producing domestic immersion DUV lithography tools. It aims to produce five units in 2026 before scaling output to 20 units in 2027.

The revenue implications are limited. Based on ASML's 2025 results, five immersion DUV systems would account for only around 1.6% of net system sales, suggesting that the earnings impact over the next one to two years is likely to be negligible.

Critically, the breakthrough relates to DUV, not EUV. ASML's monopoly in EUV lithography remains firmly intact, while China's domestic EUV efforts are reportedly still at the prototype stage.

We reaffirm our target price of USD 2,266, which implies 36% upside from ASML's closing price on 27 July 2026. If anything, the recent pullback has made the risk-reward more compelling relative to our target than it was just two weeks ago.


What happened

On 27 July 2026, ASML’s shares fell more than 8% intraday and closed roughly 6% lower following reports that a Chinese state-backed consortium had begun mass-producing domestic immersion DUV lithography tools. The first systems are expected to be delivered before year-end to major domestic chipmakers such as the likes of SMIC, Hua Hong Semiconductor, and ChangXin Memory Technologies. The consortium reportedly aims to produce five units in 2026 before scaling output to 20 units in 2027.

The news caught the market off guard, reversing an early rally in chip equipment stocks that had been driven by easing Middle East tensions and reports that Nvidia was backing a USD 250 billion financing package for OpenAI's data center expansion. Adding to the sting, the report surfaced just as the US Congress was advancing the MATCH Act, which aims to block China from buying or servicing DUV tools. 


Why the near-term impact on ASML is limited

Immersion DUV is legacy technology, one category of ASML’s tools that Chinese chipmakers can still legally purchase after EUV exports were banned, and a segment that has been a meaningful revenue cushion in China. This news chips away at that cushion, and it deserves to be taken seriously as a long-term strategic signal that China is still pursuing its goal of self-sufficiency. 

But the numbers involved remain modest. ASML alone expects to ship approximately 130 immersion DUV systems this year, meaning five domestic Chinese machines would represent just 3.8% of that volume. Even if production scales to 20 units in 2027, that will amount to only 11.8% of ASML's projected immersion DUV capacity of around 169 systems. Those are hardly the volumes needed to displace a global market leader overnight.

The revenue implications are similarly limited. Based on ASML's 2025 results, five immersion DUV systems would account for only around 1.6% of net system sales, suggesting that the earnings impact over the next one to two years is likely to be negligible.

It does not end there.

The Chinese tools reportedly still lag ASML on precision, throughput, and reliability, and require further testing before they can be deployed at scale in commercial fabs. Bridging the gap between a functioning prototype and a production-ready system remains a significant challenge.

ASML’s own 2Q26 results had already flagged softening Chinese demand, meaning the company was managing this shift well before the headlines caught up. China’s share of ASML’s business has in fact been shrinking, not growing. In 2Q26, South Korea and Taiwan together accounted for 73% of net system sales versus just 14% from China, itself down from a larger share in prior years as export restrictions have progressively narrowed what ASML can sell there. The center of gravity for ASML’s business has already moved to where AI-driven memory and logic demand actually sits.


Related Article: ASML has not gotten cheaper. Our earnings estimates have gotten bigger


The key implication of the latest development is mostly strategic, not financial. Although China's domestic lithography program appears to be making progress, it remains to be seen whether these systems can become viable substitutes for ASML's machines at commercial scale. That reinforces the need to monitor China's long-term technological trajectory, particularly if similar progress is eventually made in EUV. 

Today's announcement, however, does not materially alter ASML's earnings power over the next few years. Growth remains driven by AI-related demand outside China, while the company's exposure to China has already been reduced meaningfully over the years. 


ASML’s long-term investment thesis remains unchanged

Nothing in this development touches the pillars of our investment thesis. ASML is still the only company capable of producing EUV lithography machines commercially. High-NA EUV took a fresh step forward last quarter with Intel Foundry qualifying the platform to produce its logic chips, the first high-volume logic product made on the platform. Furthermore, we believe TSMC's eventual adoption of High-NA EUV remains a significant and largely unpriced catalyst. That opportunity still lies ahead and is unaffected by developments in China's domestic DUV capabilities. 

The AI capex cycle that underpins demand is also not slowing. ASML raised full-year 2026 revenue guidance to EUR 43–45 billion in July, its second raise in three months, and narrowed the range in the process — a signal of improving visibility, not deteriorating conditions. 2027 Low-NA EUV capacity is close to being fully booked, and the company has already secured a significant number of orders extending into 2028.

Memory has also gone from a cyclical drag to a co-equal growth engine alongside logic, with management guiding memory-related system sales to grow over 75% this year as HBM-driven fab expansion accelerates across Korea and Taiwan. Most importantly, this demand is structural rather than cyclical as lithography intensity continues to rise as chip designs become more complex.

The installed base management business, a recurring, high-margin revenue stream that is structurally insulated from China's domestic DUV competition, grew 31.8% year-on-year last quarter and continues to outpace new system sales. Each lithography system can potentially generate service and maintenance revenue over a lifespan of up to 30 years, while every new system shipped expands this installed base and strengthens ASML's recurring revenue stream. 

Putting it all together, we view this sell-off as a valuation reset rather than a break in the investment thesis. We reaffirm our target price of USD 2,266, which implies 36% upside from ASML's closing price on 27 July 2026. If anything, the recent pullback has made the risk-reward more compelling relative to our target than it was just two weeks ago.

For existing shareholders, we view this weakness as an opportunity to add to positions rather than reduce exposure. For investors not yet invested, the pullback provides a more attractive entry point into a company whose long-term growth drivers remain firmly intact.


Figure 1: Share prices are driven by earnings in the long term


Declaration:

For specific disclosure, at the time of publication of this report, IFPL (via its connected and associated entities) holds a NIL position in the abovementioned securities. The analyst who produced this report holds a position in ASML.

This research report was prepared with the assistance of artificial intelligence (AI) tools.  iFAST Financial Pte Ltd does not rely exclusively on AI for content generation; the content of this report – including all investment theses, ratings, price targets and conclusions – has been independently reviewed and verified by the research analyst(s) to ensure accuracy and professional integrity.

All materials and contents found in this site are strictly for general circulation and informational purposes only and should not be considered as an offer, or solicitation, to deal in any of the funds or products found/identified in this site. While iFAST Financial Pte Ltd ("IFPL") has tried to provide accurate and timely information, there may be inadvertent delays, omissions, technical or factual inaccuracies and typographical errors. Any opinion or estimate contained in this report is made on a general basis and neither IFPL nor any of its servants or agents have given any consideration to nor have they or any of them made any investigation of the investment objective, financial situation or particular need of any user or reader, any specific person or group of persons. You should consider carefully if the products you are going to purchase are suitable for your investment objective, investment experience, risk tolerance and other personal circumstances. If you are uncertain about the suitability of the investment product, please seek advice from a financial adviser, before making a decision to purchase the investment product. Past performance is not indicative of future performance. The value of the investment products and the income from them may fall as well as rise. Opinions expressed herein are subject to change without notice. In respect of any matters arising from, or in connection with the said research analyses or research reports, recipients of the report are to contact IFPL at 10 Collyer Quay, #26-01 Ocean Financial Centre Building, Singapore 049315, or by telephone at +65 6557 2853. Where the report contains research analyses or research reports from a foreign research house and if the recipient of such research analyses or research reports is not an accredited investor, expert investor, institutional investor or an ex-accredited investor, IFPL accepts legal responsibility for the contents of such analyses or reports to such persons only to the extent as required by law. Please note that only certain security(ies) herein are available to all investors, while the rest are only available for certain persons to invest in, such as Accredited Investors (as defined in the Securities and Futures Act) or one who invests at least S$200,000 (or its equivalent currency) per transaction. To qualify as an Accredited Investor, one needs to submit a declaration form and certain relevant supporting documents, according to iFAST’s prevailing policies and procedures.

Please read our full disclaimers on the website at ( https://fsm.global/sg/policies/328125/investment-account-terms-&-conditions).

iFAST Financial Pte Ltd (IFPL) (registered address: 10 Collyer Quay #26-01 Ocean Financial Centre Singapore 049315, Telephone: 6557 2000) holds the Financial Advisers Licence issued by the Monetary Authority of Singapore ('MAS') to conduct regulated activities of advising on securities, marketing of collective investment schemes and arranging of any contract of insurance in respect of life policies, other than a contract of reinsurance and the Capital Markets Services Licence issued by the MAS to conduct regulated activities of dealing in securities and providing custodial services for securities. While IFPL has made every effort to ensure the independence of the report's contents, IFPL's nature of business is such that IFPL and its connected and associated entities together with their respective directors, officers and staff may be involved in providing dealing or investment-related services in the abovementioned securities, and have taken or may take positions in the securities mentioned in this report, and may also act as the principal for any buy or sell trades.